Ranked by reported Q2 2026 13F market value
Share of total reported institutional value in RXRX held by the largest 10 / 25 filers.
| # | Institution | Shares Held | Market Value | QoQ Change | Ownership % | % of Fund |
|---|---|---|---|---|---|---|
| 1 | BlackRock, Inc. | 50.3M | $184.6M | +16.5% | 9.588% | 0.00% |
| 2 | ARK Investment Management LLC | 41.3M | $151.7M | +2.8% | 7.879% | 0.98% |
| 3 | STATE STREET CORP | 34.7M | $127.4M | +21.8% | 6.615% | 0.00% |
| 4 | VANGUARD PORTFOLIO MANAGEMENT LLC | 31.1M | $114.3M | +36.8% | 5.933% | 0.01% |
| 5 | BAILLIE GIFFORD & CO | 23.5M | $86.2M | -0.8% | 4.477% | 0.08% |
| 6 | VANGUARD CAPITAL MANAGEMENT LLC | 22.8M | $83.6M | +2.3% | 4.339% | 0.00% |
| 7 | GEODE CAPITAL MANAGEMENT, LLC | 13.8M | $50.7M | +12.6% | 2.634% | 0.00% |
| 8 | SOFTBANK GROUP CORP. | 13.6M | $50.0M | 0.0% | 2.599% | 0.28% |
| 9 | MIC Capital Management UK LLP | 9.6M | $35.4M | 0.0% | 1.838% | 8.98% |
| 10 | UBS Group AG | 8.9M | $32.8M | +73.9% | 1.705% | 0.00% |
| 11 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | 8.0M | $29.5M | -4.1% | 1.533% | 0.00% |
| 12 | NORGES BANK | 6.8M | $25.1M | — | 1.302% | 0.00% |
| 13 | Data Collective IV GP, LLC | 5.9M | $21.8M | 0.0% | 1.132% | 27.76% |
| 14 | Sumitomo Mitsui Trust Group, Inc. | 5.5M | $20.2M | +1.7% | 1.050% | 0.01% |
| 15 | Amova Asset Management Americas, Inc. | 5.5M | $20.2M | +1.7% | 1.050% | 0.26% |
| 16 | NORTHERN TRUST CORP | 4.8M | $17.5M | +19.9% | 0.907% | 0.00% |
| 17 | MARSHALL WACE, LLP | 4.7M | $17.3M | +63.9% | 0.899% | 0.01% |
| 18 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 4.1M | $15.2M | +8.6% | 0.789% | 0.00% |
| 19 | DCVC Opportunity Fund II GP, LLC | 4.0M | $14.5M | 0.0% | 0.753% | 84.30% |
| 20 | GOLDMAN SACHS GROUP INC | 3.9M | $14.4M | -35.4% | 0.747% | 0.00% |
| 21 | VANGUARD FIDUCIARY TRUST CO | 3.5M | $12.7M | -1.3% | 0.661% | 0.00% |
| 22 | TWO SIGMA INVESTMENTS, LP | 3.4M | $12.3M | -17.5% | 0.639% | 0.01% |
| 23 | FIRST TRUST ADVISORS LP | 3.0M | $11.2M | +16.5% | 0.580% | 0.01% |
| 24 | MORGAN STANLEY | 2.7M | $10.1M | +25.5% | 0.523% | 0.00% |
| 25 | IQ EQ FUND MANAGEMENT (IRELAND) Ltd | 2.6M | $9.6M | +1.8% | 0.496% | 0.61% |
denotes a marquee investor (Buffett, Burry, ARK, Tiger Global, Pershing Square, Baupost and other widely-followed managers). “% of Fund” shows how much of that investor’s total 13F portfolio is invested in RXRX — a direct measure of their conviction.
Filings activity in RXRX during Q2 2026, grouped by how each filer changed its position.
8 quarters of 13F filings · Δ columns show change vs prior quarter
| Quarter | Inst. Holders | Δ Holders | Ownership % | Δ Ownership | Total 13F Value | Δ Value |
|---|---|---|---|---|---|---|
| Q2 2026 | 350 | +2.9% | 70.76% | +4.84 pp | $1.36B | +29% |
| Q1 2026 | 340 | +2.7% | 65.92% | +1.06 pp | $1.05B | 23% |
| Q4 2025 | 331 | +4.1% | 64.86% | 4.93 pp | $1.36B | 17% |
| Q3 2025 | 318 | 1.9% | 69.79% | 4.43 pp | $1.64B | +4.1% |
| Q2 2025 | 324 | 1.8% | 74.22% | 2.09 pp | $1.58B | 1.2% |
| Q1 2025 | 330 | +6.8% | 76.31% | 2.07 pp | $1.60B | 22% |
| Q4 2024 | 309 | +19% | 78.38% | 13.76 pp | $2.05B | +21% |
| Q3 2024 | 260 | — | 92.14% | — | $1.69B | — |
Source: SEC 13F institutional filings. Ownership % requires market cap data and will show once linked. Δ columns compare to the immediately prior filed quarter.
Quick answers to the most common questions about buying RXRX stock.
Based on Q2 2026 13F filings, institutional ownership of Recursion Pharmaceuticals, Inc. stands at 70.8%, held across 350 reporting institutions.
BlackRock, Inc. is the largest reported institutional holder of RXRX, with approximately 50,304,691 shares worth $0.18B as of Q2 2026.
Yes — 3 widely-followed marquee investors appear among the top 25 institutional holders of RXRX, including ARK Investment Management LLC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, TWO SIGMA INVESTMENTS, LP.
Our composite Smart Money Score for RXRX is 72 out of 100 (Bullish). It combines net institutional buying activity, ownership shift, marquee investor presence, and holder-count growth.
44 institutions opened new positions in RXRX during Q2 2026, while 40 fully exited. 232 added to existing positions and 59 trimmed.
RXRX institutional ownership rose by 4.84 percentage points quarter-over-quarter, with a net change of +10 holders.
The top 10 institutions account for 67.6% of all reported 13F value in RXRX, and the top 25 account for 86.2%.
All data is sourced from SEC Form 13F filings, which institutional investment managers with at least $100M in assets are required to file each quarter. We process every 13F filing from EDGAR and recompute the aggregates after each cycle. Insider transactions are sourced from Form 4 filings.
Recursion Pharmaceuticals, Inc. (RXRX) Institutional Ownership